Growth Metrics

Novartis Ag (NVS) EPS (Basic) (QoQ) (2009 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 -99.74%
Sep 30, 2023 161,129,822,312.74%
Jun 30, 2023 -100.00%
Mar 31, 2023 198,071.47%
Dec 31, 2022 -99.94%
Sep 30, 2022 -96.05%
Jun 30, 2022 435,378,530,973.45%
Mar 31, 2022 -100.00%
Dec 31, 2021 374,012,606.11%
Sep 30, 2021 -73.30%
Jun 30, 2021 373.96%
Mar 31, 2021 -100.00%
Dec 31, 2020 328,801,405.85%
Sep 30, 2020 -89.21%
Jun 30, 2020 2,859.32%
Mar 31, 2019 100.00%
Dec 31, 2018 -10,077,419.38%
Sep 30, 2018 -100.00%
Jun 30, 2018 20,128,790,926.17%
Mar 31, 2018 -100.00%
Dec 31, 2017 -99.78%
Sep 30, 2017 -91.23%
Jun 30, 2017 268.87%
Mar 31, 2017 9,329.02%
Dec 31, 2016 -96.37%
Sep 30, 2016 -37.66%
Jun 30, 2016 60.81%
Mar 31, 2016 10,784,331.93%
Dec 31, 2015 -99.99%
Sep 30, 2015 141,308,343.73%
Jun 30, 2015 -104.38%
Mar 31, 2015 336.84%
Dec 31, 2014 -657.43%
Sep 30, 2014 162.31%
Jun 30, 2014 -112.66%
Sep 30, 2013 194.97%
Sep 30, 2012 -40.13%
Jun 30, 2012 68,980,273.82%
Mar 31, 2012 -100.00%
Dec 31, 2011 61.63%
Sep 30, 2011 -67.49%
Jun 30, 2011 -15.75%
Mar 31, 2011 400.40%
Dec 31, 2010 -36.36%
Sep 30, 2010 -58.18%
Jun 30, 2010 -83.83%
Sep 30, 2009 40,234.57%
Jun 30, 2009 -99.91%